DM RWE
Sana Kagermazova has extensive experience in the pharmaceutical and biomedical sectors, currently working at DM RWE since September 2022, focusing on Real World Data and Real World Evidence studies. Previously, Kagermazova served as Post Market Safety Surveillance Manager for AbbVie and Allergan in the CIS and Ukraine regions, implementing comprehensive safety surveillance systems and managing pharmacovigilance processes. At Skolkovo Foundation, projects involved scouting innovative biomedical startups and securing governmental partnerships. Early career highlights include roles at Bristol-Myers Squibb managing post-market pharmacovigilance and conducting market research at MRC Pharmexpert. Kagermazova holds a Doctor of Pharmacy degree specializing in Pharmaceutical Marketing and Management from Peoples’ Friendship University of Russia.
This person is not in any offices
DM RWE
DM RWE offers a wide-range of Real World Evidence (RWE) solutions with access to millions of electronic health records. DM RWE is developing unique AI algorithms to collect curated data derived from millions of electronic health records (EHRs). In-house designed tools empowered with AI employed to clean, curate, bridge, harmonize, validateReal-World Data to generate evidence for comprehensive clinical research projects.To mine valuable datasets company is building the broad network of healthcare organizations and data providers from EU, CIS, MENA and APAC.